Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Yagen

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|July 25, 2013
Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticusNaama Hen, Tawfeeq Shekh-Ahmad, Boris Yagen, et al.
Neuropharmacology|March 17, 2010
Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acidDan Kaufmann, Boris Yagen, Anne Minert, et al.
Epilepsia|December 10, 2013
Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potentialTawfeeq Shekh-Ahmad, Naama Hen, Boris Yagen, et al.
Epilepsy Research|September 26, 2006
Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamideEyal Sobol, Boris Yagen, John G Lamb, et al.
Pharmaceutical Research|September 2, 2003
Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsyNina Isoherranen, H Steve White, Brian D Klein, et al.
Journal of Medicinal Chemistry|April 22, 2011
Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIVNaama Hen, Meir Bialer, Boris Yagen, et al.
Cephalalgia : an International Journal of Headache|November 17, 2015
sec-Butylpropylacetamide (SPD) has antimigraine propertiesDan Kaufmann, Emily A Bates, Boris Yagen, et al.
Pharmacological Research|November 29, 2016
sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory painDan Kaufmann, Peter J West, Misty D Smith, et al.
British Journal of Pharmacology|June 19, 2003
Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in miceNina Isoherranen, Boris Yagen, Ofer Spiegelstein, et al.
Epilepsia|September 27, 2003
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicityNina Isoherranen, Ofer Spiegelstein, Meir Bialer, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|July 25, 2013
Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticusNaama Hen, Tawfeeq Shekh-Ahmad, Boris Yagen, et al.
Neuropharmacology|March 17, 2010
Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acidDan Kaufmann, Boris Yagen, Anne Minert, et al.
Epilepsia|December 10, 2013
Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potentialTawfeeq Shekh-Ahmad, Naama Hen, Boris Yagen, et al.
Epilepsy Research|September 26, 2006
Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamideEyal Sobol, Boris Yagen, John G Lamb, et al.
Pharmaceutical Research|September 2, 2003
Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsyNina Isoherranen, H Steve White, Brian D Klein, et al.
Journal of Medicinal Chemistry|April 22, 2011
Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIVNaama Hen, Meir Bialer, Boris Yagen, et al.
Cephalalgia : an International Journal of Headache|November 17, 2015
sec-Butylpropylacetamide (SPD) has antimigraine propertiesDan Kaufmann, Emily A Bates, Boris Yagen, et al.
Pharmacological Research|November 29, 2016
sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory painDan Kaufmann, Peter J West, Misty D Smith, et al.
British Journal of Pharmacology|June 19, 2003
Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in miceNina Isoherranen, Boris Yagen, Ofer Spiegelstein, et al.
Epilepsia|September 27, 2003
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicityNina Isoherranen, Ofer Spiegelstein, Meir Bialer, et al.
Pageof 5